Literature DB >> 25022938

Longitudinal course of cortical thickness decline in amyotrophic lateral sclerosis.

Christina Schuster1, Elisabeth Kasper, Judith Machts, Daniel Bittner, Jörn Kaufmann, Reiner Benecke, Stefan Teipel, Stefan Vielhaber, Johannes Prudlo.   

Abstract

To determine longitudinal rates of cortical atrophy in classical Amyotrophic lateral sclerosis (ALS) and ALS variants. Rates of cortical thinning were determined between 2 scans, 3-15 months apart, in 77 ALS patients: 51 classical, 12 upper motor neuron (UMN), and 14 lower motor neuron (LMN) ALS variants. Cortical thickness at the first assessment was compared with 60 healthy controls matched by age and gender. Atrophy rates were compared between patient sub-groups and correlated with disease duration, progression, and severity. Using a cross-sectional analysis, we found a significant difference in cortical thickness between ALS patients and controls in the motor and extra-motor areas (left medial orbito frontal gyrus, left inferior parietal gyrus, bilateral insular cortex, right fusiform gyrus, bilateral precuneus). Using a longitudinal analysis, we found a significant decline of cortical thickness in frontal, temporal, and parietal regions over the course of the study in ALS patients. Effects were independent of the clinical subtype, with exception of the precentral gyrus (p < 0.001). The LMN ALS variants demonstrated the highest rates of cortical thinning in the precentral gyrus, the UMN-dominant subjects exhibited intermediate rates of atrophy, and the classical ALS patients exhibited no such change. Atrophy of the precentral gyrus in classical ALS indicates a floor effect at the first assessment, resulting in a lack of further atrophy over time. Structural loss of the precentral gyrus appears to be an early sign of classical ALS. Over time, patterns of cortical thinning in extra-motor areas can be identified in ALS, regardless of the phenotype.

Entities:  

Mesh:

Year:  2014        PMID: 25022938     DOI: 10.1007/s00415-014-7426-4

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  36 in total

Review 1.  El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis.

Authors:  B R Brooks; R G Miller; M Swash; T L Munsat
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  2000-12

2.  Focal thinning of the motor cortex mirrors clinical features of amyotrophic lateral sclerosis and their phenotypes: a neuroimaging study.

Authors:  Christina Schuster; Elisabeth Kasper; Judith Machts; Daniel Bittner; Jörn Kaufmann; Reiner Benecke; Stefan Teipel; Stefan Vielhaber; Johannes Prudlo
Journal:  J Neurol       Date:  2013-08-31       Impact factor: 4.849

3.  Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity.

Authors:  H Diana Rosas; David H Salat; Stephanie Y Lee; Alexandra K Zaleta; Vasanth Pappu; Bruce Fischl; Doug Greve; Nathanael Hevelone; Steven M Hersch
Journal:  Brain       Date:  2008-03-12       Impact factor: 13.501

4.  Cortical surface-based analysis. II: Inflation, flattening, and a surface-based coordinate system.

Authors:  B Fischl; M I Sereno; A M Dale
Journal:  Neuroimage       Date:  1999-02       Impact factor: 6.556

5.  Classification of primary progressive aphasia and its variants.

Authors:  M L Gorno-Tempini; A E Hillis; S Weintraub; A Kertesz; M Mendez; S F Cappa; J M Ogar; J D Rohrer; S Black; B F Boeve; F Manes; N F Dronkers; R Vandenberghe; K Rascovsky; K Patterson; B L Miller; D S Knopman; J R Hodges; M M Mesulam; M Grossman
Journal:  Neurology       Date:  2011-02-16       Impact factor: 9.910

6.  Structural MRI reveals cortical thinning in amyotrophic lateral sclerosis.

Authors:  Esther Verstraete; Jan H Veldink; Jeroen Hendrikse; H Jurgen Schelhaas; Martijn P van den Heuvel; Leonard H van den Berg
Journal:  J Neurol Neurosurg Psychiatry       Date:  2011-09-29       Impact factor: 10.154

7.  Pattern of spread and prognosis in lower limb-onset ALS.

Authors:  Martin R Turner; Alice Brockington; Jakub Scaber; Hannah Hollinger; Rachael Marsden; Pamela J Shaw; Kevin Talbot
Journal:  Amyotroph Lateral Scler       Date:  2010-08

8.  Motor network degeneration in amyotrophic lateral sclerosis: a structural and functional connectivity study.

Authors:  Esther Verstraete; Martijn P van den Heuvel; Jan H Veldink; Niels Blanken; René C Mandl; Hilleke E Hulshoff Pol; Leonard H van den Berg
Journal:  PLoS One       Date:  2010-10-27       Impact factor: 3.240

9.  Study of 962 patients indicates progressive muscular atrophy is a form of ALS.

Authors:  W-K Kim; X Liu; J Sandner; M Pasmantier; J Andrews; L P Rowland; H Mitsumoto
Journal:  Neurology       Date:  2009-11-17       Impact factor: 9.910

10.  Is language impairment more common than executive dysfunction in amyotrophic lateral sclerosis?

Authors:  Lorna J Taylor; Richard G Brown; Stella Tsermentseli; Ammar Al-Chalabi; Christopher E Shaw; Catherine M Ellis; P Nigel Leigh; Laura H Goldstein
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-10-02       Impact factor: 10.154

View more
  21 in total

1.  Age at symptom onset influences cortical thinning distribution and survival in amyotrophic lateral sclerosis.

Authors:  Pilar M Ferraro; Corrado Cabona; Giuseppe Meo; Claudia Rolla-Bigliani; Lucio Castellan; Matteo Pardini; Matilde Inglese; Claudia Caponnetto; Luca Roccatagliata
Journal:  Neuroradiology       Date:  2021-03-04       Impact factor: 2.804

2.  Perfusion alterations converge with patterns of pathological spread in transactive response DNA-binding protein 43 proteinopathies.

Authors:  Pilar M Ferraro; Charles Jester; Christopher A Olm; Katerina Placek; Federica Agosta; Lauren Elman; Leo McCluskey; David J Irwin; John A Detre; Massimo Filippi; Murray Grossman; Corey T McMillan
Journal:  Neurobiol Aging       Date:  2018-04-17       Impact factor: 4.673

3.  Structural brain correlates of cognitive and behavioral impairment in MND.

Authors:  Federica Agosta; Pilar M Ferraro; Nilo Riva; Edoardo G Spinelli; Adriano Chiò; Elisa Canu; Paola Valsasina; Christian Lunetta; Sandro Iannaccone; Massimiliano Copetti; Evelina Prudente; Giancarlo Comi; Andrea Falini; Massimo Filippi
Journal:  Hum Brain Mapp       Date:  2016-02-02       Impact factor: 5.038

4.  Structural and diffusion imaging versus clinical assessment to monitor amyotrophic lateral sclerosis.

Authors:  Arturo Cardenas-Blanco; Judith Machts; Julio Acosta-Cabronero; Joern Kaufmann; Susanne Abdulla; Katja Kollewe; Susanne Petri; Stefanie Schreiber; Hans-Jochen Heinze; Reinhard Dengler; Stefan Vielhaber; Peter J Nestor
Journal:  Neuroimage Clin       Date:  2016-03-16       Impact factor: 4.881

5.  Marked changes in dendritic structure and spine density precede significant neuronal death in vulnerable cortical pyramidal neuron populations in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.

Authors:  Matthew J Fogarty; Erica W H Mu; Peter G Noakes; Nickolas A Lavidis; Mark C Bellingham
Journal:  Acta Neuropathol Commun       Date:  2016-08-04       Impact factor: 7.801

6.  Survival prediction in Amyotrophic lateral sclerosis based on MRI measures and clinical characteristics.

Authors:  Christina Schuster; Orla Hardiman; Peter Bede
Journal:  BMC Neurol       Date:  2017-04-17       Impact factor: 2.474

7.  Structural MRI outcomes and predictors of disease progression in amyotrophic lateral sclerosis.

Authors:  Edoardo G Spinelli; Nilo Riva; Paola M V Rancoita; Paride Schito; Alberto Doretti; Barbara Poletti; Clelia Di Serio; Vincenzo Silani; Massimo Filippi; Federica Agosta
Journal:  Neuroimage Clin       Date:  2020-06-17       Impact factor: 4.881

8.  Longitudinal Study of Cognitive and Emotional Alterations in Amyotrophic Lateral Sclerosis: Clinical and Imaging Data.

Authors:  Soumia Benbrika; Franck Doidy; Laurence Carluer; Audrey Mondou; Alice Pélerin; Francis Eustache; Fausto Viader; Béatrice Desgranges
Journal:  Front Neurol       Date:  2021-07-08       Impact factor: 4.003

Review 9.  Recent advances in amyotrophic lateral sclerosis.

Authors:  Nilo Riva; Federica Agosta; Christian Lunetta; Massimo Filippi; Angelo Quattrini
Journal:  J Neurol       Date:  2016-03-30       Impact factor: 4.849

Review 10.  Neuroimaging Endpoints in Amyotrophic Lateral Sclerosis.

Authors:  Ricarda A L Menke; Federica Agosta; Julian Grosskreutz; Massimo Filippi; Martin R Turner
Journal:  Neurotherapeutics       Date:  2017-01       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.